Please select the option that best describes you:
With immunotherapy now often being used in the first-line setting for advanced endometrial cancer, what is the role of immunotherapy in the second-line?
Does the patient's MMR status affect your opinions? What is/are your current preferred second-line regimen(s)?
Answer from: at Community Practice
This is a relevant and important question that we have yet to definitively answer. Furthermore, it may depend on several factors such as progression while receiving front line maintenance immunotherapy versus progression after completion of maintenance treatment, or progression after discontinuation...
Sign in or Register to read more